Instil Bio Inc. (TIL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $41.23M
Last updated: Nov 17, 2026 at 4:10 PM ET
Instil Bio Inc. (TIL) Statistics
Instil Bio (TIL) has a market cap of $41.23M and an enterprise value of $123.75M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its net debt of $82.51M equals 200.11% of its market cap.
Total Valuation
Enterprise value is 200.11% above the market cap, as debt exceeds cash.
| Market Cap | $41.23M |
|---|---|
| Enterprise Value | $123.75M |
| Latest price (Nov 17, 2026) | $5.40 |
Key Dates
The next earnings report is expected on Mar 25, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 25, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 16, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 62.55% over 52 weeks and trades 18.80% below its 50-day average.
| Beta (1Y) | 0.42 |
|---|---|
| 52-Week Change | -62.55% |
| 1-Month Change | -6.74% |
| 3-Month Change | -26.93% |
| 6-Month Change | -32.67% |
| 5-Year Change | -98.33% |
| Total Return (1Y) | -62.55% |
| Total Return (3Y CAGR) | -9.14% |
| Total Return (5Y CAGR) | -58.67% |
| Return vs SPY (1Y) | -70.02% |
| Max Drawdown (1Y) | -58.90% |
| Max Drawdown (3Y) | -93.61% |
| Sharpe Ratio (1Y) | -1.14 |
| Correlation with SPY (1Y) | 0.07 |
| 50-Day Average | $6.65 |
| 200-Day Average | $7.64 |
| 52-Week Range | $5.28 to $13.50 |
| RSI (14 Days) | 31.0 |
| Average Volume (20 Days) | 75.74K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 10.42x current liabilities, and total debt is 0.83x shareholder equity.
| Current Ratio | 10.42x |
|---|---|
| Quick Ratio | 10.42x |
| Debt / Equity | 0.83x |
| Interest Coverage | -4.54x |
Returns and Efficiency
Return on invested capital is -11.95% over the last 12 months, against a 5-year average of -37.03%.
| Return on Equity (ROE) | -20.40% |
|---|---|
| Return on Assets (ROA) | -10.70% |
| Return on Invested Capital (ROIC) | -11.95% |
| ROE (5Y Average) | -53.17% |
| ROA (5Y Average) | -36.59% |
| ROIC (5Y Average) | -37.03% |
Scores
TIL has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$12.00K |
| Operating Income | -$28.13M |
| Pretax Income | -$20.91M |
| Net Income | -$20.93M |
| Reported EPS (TTM) | -$2.84 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 52.42% of the $195.65M in total assets.
| Cash and Equivalents | $2.54M |
|---|---|
| Total Debt | $85.06M |
| Net Debt | $82.51M |
| Net Debt Per Share | $12.17 |
| Working Capital | $59.22M |
| Shareholder Equity | $102.56M |
| Book Value Per Share | $15.12 |
| Total Assets | $195.65M |
| Total Liabilities | $93.08M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$15.46M |
|---|---|
| FCF Per Share | -$2.28 |
| Depreciation and Amortization | $1.33M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -30.83% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -30.83% |
Stock Splits
The last split was a 1-for-20 reverse split on Dec 8, 2023.
| Last Split Date | Dec 8, 2023 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About TIL
What is TIL's market cap?
Instil Bio has a market cap of $41.23M. Its enterprise value, which adds debt and subtracts cash, is $123.75M.
How many shares of TIL are outstanding?
Instil Bio has 6.78M shares outstanding. The count is up 0.36% from a year earlier.
Does TIL pay a dividend?
No. Instil Bio does not pay a dividend.
How much debt does TIL have?
Instil Bio has $85.06M of total debt and $2.54M of cash and equivalents, a net debt position of $82.51M.
TIL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors